Multispan Revenue and Competitors
Estimated Revenue & Valuation
- Multispan's estimated annual revenue is currently $1.9M per year.
- Multispan's estimated revenue per employee is $155,000
Employee Data
- Multispan has 12 Employees.
- Multispan grew their employee count by -33% last year.
Multispan's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Founder | Reveal Email/Phone |
2 | Research Associate | Reveal Email/Phone |
3 | Scientist II | Reveal Email/Phone |
Multispan Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Multispan?
Multispan, Inc. is a premier assay screening technology provider targeting GPCRs, kinases and beyond using endogenously expressed targets in primary cells and recombinant stable cell lines. It has created the industry’s largest, highly characterized, highest quality GPCR-expressing stable cell lines and assays based on cell signaling and phenotypic biology. Multispan offers integrated high quality solutions in assay development, HTS and SAR lead optimization screening support to shorten time to IND and discover better medicine in cardiovascular, metabolic, CNS, inflammation, immunology and oncology diseases. Multispan’s high standard of quality and integrity has earned successful long-term collaborations with a wide range of leading pharmaceutical and biotech companies globally.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1.5M | 12 | -14% | N/A |
#4 | N/A | 14 | 0% | N/A |
#5 | $1.3M | 15 | -6% | N/A |